|
|
|
|
|
|
Sponsored by: |
University of Michigan |
Information provided by: | University of Michigan |
ClinicalTrials.gov Identifier: | NCT00723671 |
The purpose of this study is to find out if certain types of Magnetic Resonance (MR) scanning will help to better detect markers in the brain that are related to the neuropsychiatric symptoms of systemic lupus erythematosus (SLE). A small percentage of patients who have this type of lupus experience symptoms that may result from a blood clot or change in blood vessel structure in the brain. These neuropsychiatric symptoms can include an inability to think clearly, a change in level of awake and/or awareness, and in the worst cases, seizure and stroke. Another goal of the study is to find out if individuals with fibromyalgia (FM), or chronic pain, have symptom-related markers in any of these scans as well. Better and earlier detection of markers that are related to acute neuropsychiatric lupus (NPSLE) and FM will be helpful to all who are affected by these diseases.
Condition | Intervention |
Systemic Lupus Erythematosus Fibromyalgia Acute Neuropsychiatric Lupus |
Other: MRI |
MedlinePlus related topics: | Fibromyalgia Lupus |
Study Type: | Interventional |
Study Design: | Diagnostic, Non-Randomized |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:Inclusion Criteria:
Exclusion Criteria:
Contact: Pia M Sundgren, MD, PhD | 734.763.3253 | sundgren@med.umich.edu |
United States, Michigan | |||||
University of Michigan Hospital | Recruiting | ||||
Ann Arbor, Michigan, United States, 48109 |
University of Michigan |
Responsible Party: | UNiversity of Michigan Department of Radiology ( Pia Maly Sundgren ) |
Study ID Numbers: | 2003-0199 |
First Received: | July 25, 2008 |
Last Updated: | July 25, 2008 |
ClinicalTrials.gov Identifier: | NCT00723671 |
Health Authority: | United States: Institutional Review Board |
|
|
|